{"company": {"org_id": "T000038181", "org_name_cn": "深圳翰宇药业股份有限公司", "org_short_name_cn": "翰宇药业", "org_name_en": "Hybio Pharmaceutical Co.,Ltd.", "org_short_name_en": "HYBIO", "main_operation_business": "多肽药物研发、生产和销售。", "operating_scope": "　　一般经营项目是：经营进出口业务（法律、行政法规、国务院决定禁止的项目除外，限制的项目须取得许可后方可经营）；非居住房地产租赁；医学研究和试验发展；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动），许可经营项目是：生产经营片剂、硬胶囊剂、颗粒剂、小容量注射剂、冻干粉针剂、原料药（按照《药品生产许可证》批准的种类生产）。", "district_encode": "440309", "org_cn_introduction": "深圳翰宇药业股份有限公司的主营业务是多肽药物研发、生产和销售。公司的主要产品是多肽制剂、多肽原料药、小核酸、CDMO/CMO。公司共获得国内专利授权298件，其中发明专利291件；翰宇药业（武汉）获得国内专利授权18件；成纪药业共获得国内专利授权115件。", "legal_representative": "曾少贵", "general_manager": "曾少贵", "secretary": "杨笛", "established_date": 1049212800000, "reg_asset": 883241336.0, "staff_num": 1035, "telephone": "86-755-26588036", "postcode": "518110", "fax": "86-755-26588022", "email": "hy@hybio.com.cn", "org_website": "www.hybio.com.cn", "reg_address_cn": "广东省深圳市龙华区观澜高新园区观盛四路7号翰宇创新产业大楼", "reg_address_en": null, "office_address_cn": "广东省深圳市龙华区观澜高新园区观盛四路7号翰宇创新产业大楼", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1302105600000, "provincial_name": "广东省", "actual_controller": "曾少贵 (11.16%)，曾少强 (7.15%)，曾少彬 (2.73%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "曾少贵", "executives_nums": 14, "actual_issue_vol": 25000000.0, "issue_price": 30.19, "actual_rc_net_amt": 715025800.0, "pe_after_issuing": 67.09, "online_success_rate_of_issue": 1.27854231, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}}